BioSpace News Archive

Business

Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Longeveron Inc. today provided a business update and reported its financial results for the second quarter ended June 30, 2022.

August 12, 2022
·
17 min read
Business

Zeta Surgical Appoints Professor James Choi as Focused Ultrasound Lead in Push for Incision-less Brain Surgery

Zeta Surgical, a surgical robotics and mixed reality company, has appointed Dr. James Choi from Imperial College London as Focused Ultrasound Lead.

August 12, 2022
·
2 min read
Pharm Country

MPS Clinical Program Update and Paradigm to Present at the International Conference on Lysosomal Diseases

Paradigm has been invited to present results from the mucopolysaccharidosis (MPS ) program, with an oral presentation at the XVII International Conference on Lysosomal Diseases (ICLD 2023 ), to be held in Sydney, Australia , February 20-21, 2023.

August 12, 2022
·
10 min read
Pharm Country

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Aug 12, 2022

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to seven new employees.

August 12, 2022
·
3 min read
FDA

FDA Approves First NGS-Based Companion Diagnostic to Aid in Selecting Non-Small Cell Lung Cancer Patients with HER2 (ERBB2) Activating Mutations (SNVs & Exon 20 Insertions) for Treatment with ENHERTU

The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors have a HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion) in non-small cell lung cancer (NSCLC).

August 12, 2022
·
3 min read
Biotech Bay

Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency

Cerus Corporation (Nasdaq: CERS) acknowledges the U.S. Department of Health and Human Services’ declaration of monkeypox as a national Public Health Emergency.

August 12, 2022
·
3 min read
Business

Xenetic Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

Xenetic Biosciences, Inc. today reported its financial results for the second quarter of 2022 and provided a business update.

August 12, 2022
·
9 min read
Business

Neptune to Report Fiscal First Quarter 2023 Financial Results on August 15, 2022

Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), announced today that it will report its financial results for the first quarter of fiscal 2023 after the market closes on Monday, August 15, 2022.

August 12, 2022
·
2 min read
Business

Progressive Care Reports Second Quarter 2022 Results Highlighted by 4% Growth to $10.0 Million in Revenue

Progressive Care, Inc., a personalized healthcare services and technology provider, announced financial and operational results for the three and six months ended June 30, 2022.

August 12, 2022
·
8 min read
Hemostemix Announces Closing of Second Tranche of UNIT Private Placement

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) announces that it has closed a second tranche of its previously announced non-brokered private placement of units (“Units”) as announced on May 19, 2022 for gross proceeds of $1,364,710.10 (the “Offering”).

August 12, 2022
·
8 min read